Dyadic International received a deficiency notice from Nasdaq on September 25, 2026, for failing to maintain the minimum bid price of $1 per share and a minimum Market Value of Listed Securities (MVLS) of $35 million for the last 30 consecutive business days. The company has until March 24, 2027, to regain compliance by achieving these thresholds for ten consecutive business days. Failure to comply may result in delisting proceedings. Dyadic International operates in the biotechnology industry, developing microbial protein production platforms.
